CA2010022A1 - Composes anesthesiques oraux - Google Patents

Composes anesthesiques oraux

Info

Publication number
CA2010022A1
CA2010022A1 CA2010022A CA2010022A CA2010022A1 CA 2010022 A1 CA2010022 A1 CA 2010022A1 CA 2010022 A CA2010022 A CA 2010022A CA 2010022 A CA2010022 A CA 2010022A CA 2010022 A1 CA2010022 A1 CA 2010022A1
Authority
CA
Canada
Prior art keywords
anesthetic
aminopropiophenone
saccharin
beta
ing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2010022A
Other languages
English (en)
Other versions
CA2010022C (fr
Inventor
William Joseph Kelleher
William John Mcclintock
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richardson Vicks Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2010022A1 publication Critical patent/CA2010022A1/fr
Application granted granted Critical
Publication of CA2010022C publication Critical patent/CA2010022C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002010022A 1989-02-15 1990-02-14 Composes anesthesiques oraux Expired - Fee Related CA2010022C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US311,155 1989-02-15
US07/311,155 US4931473A (en) 1989-02-15 1989-02-15 Anesthetic oral compositions

Publications (2)

Publication Number Publication Date
CA2010022A1 true CA2010022A1 (fr) 1990-08-15
CA2010022C CA2010022C (fr) 1996-03-05

Family

ID=23205653

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002010022A Expired - Fee Related CA2010022C (fr) 1989-02-15 1990-02-14 Composes anesthesiques oraux

Country Status (10)

Country Link
US (1) US4931473A (fr)
EP (1) EP0383481B1 (fr)
JP (1) JPH03197427A (fr)
AU (1) AU639436B2 (fr)
CA (1) CA2010022C (fr)
DE (1) DE69006041T2 (fr)
ES (1) ES2062329T3 (fr)
FI (1) FI900724A0 (fr)
IE (1) IE63154B1 (fr)
NZ (1) NZ232537A (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580577A (en) * 1990-01-11 1996-12-03 Herzenberg; Leonard A. Method of treating the symptoms of human rhinovirus infection
US5100898A (en) * 1990-01-25 1992-03-31 Richardson-Vicks Inc. Antitussive liquid compositions containing dyclonine
GB9523833D0 (en) * 1995-11-22 1996-01-24 Boots Co Plc Medical treatment
WO2000066616A1 (fr) * 1999-05-03 2000-11-09 Advanced Research & Technology Institute, Inc. Procedes et compositions permettant de lutter contre les caries dentaires, et polypeptides smaa recombines utilises a cet effet
US20160060235A1 (en) * 2013-03-29 2016-03-03 National University Corporation Kumamoto University Therapeutic Agent for Type 2 Diabetes
IT201600098338A1 (it) * 2016-09-30 2018-03-30 Univ Degli Studi Padova Composti 1-fenilpropanone e loro impiego

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2298767A (en) * 1940-06-03 1942-10-13 Union Special Machine Co Closure hinge means
US2868689A (en) * 1956-10-09 1959-01-13 Allied Lab Inc Pharmaceutical preparations containing dyclonine hydrochloride and chlorobutanol
BE569430A (fr) * 1957-07-17
US3231531A (en) * 1960-07-13 1966-01-25 Ferro Corp Polyvinyl chloride resins stabilized with a combination of a calcium salt, zinc salt, a phosphorus compound, and a sulphate or saccharin
US3138528A (en) * 1962-05-01 1964-06-23 Olin Mathieson Stable, aqueous solutions of 21-phosphate esters of 21-hydroxy steroids
US3511914A (en) * 1967-01-31 1970-05-12 Schering Corp Throat lozenge vehicle
US3832460A (en) * 1971-03-19 1974-08-27 C Kosti Anesthetic-vasoconstrictor-antihistamine composition for the treatment of hypertrophied oral tissue
US4139627A (en) * 1977-10-06 1979-02-13 Beecham Inc. Anesthetic lozenges
US4140772A (en) * 1978-02-21 1979-02-20 Dart Industries Inc. Stabilized hydrogen peroxide solutions
US4499108A (en) * 1983-06-08 1985-02-12 Schering Corporation Stable pleasant-tasting albuterol sulfate pharmaceutical formulations
US4808410A (en) * 1987-12-16 1989-02-28 Richardson-Vicks Inc. Pharmaceutical compositions containing dyclonine HC1 and phenol

Also Published As

Publication number Publication date
FI900724A0 (fi) 1990-02-14
IE63154B1 (en) 1995-03-22
DE69006041T2 (de) 1994-08-11
US4931473A (en) 1990-06-05
AU4939690A (en) 1990-08-23
NZ232537A (en) 1992-11-25
IE900537L (en) 1990-08-15
EP0383481A2 (fr) 1990-08-22
AU639436B2 (en) 1993-07-29
ES2062329T3 (es) 1994-12-16
EP0383481A3 (fr) 1991-04-10
EP0383481B1 (fr) 1994-01-19
CA2010022C (fr) 1996-03-05
DE69006041D1 (de) 1994-03-03
JPH03197427A (ja) 1991-08-28

Similar Documents

Publication Publication Date Title
DE3876877D1 (de) Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus.
CA2093806A1 (fr) Methode de traitement ou de prevention du diabete de type 1 par l'administration orale d'insuline
ITMI922953A1 (it) Inibitori a doppia attivita' biologica di no sintasi e cicloossigenasi procedimento per la loro preparazione e composizioni terapeutiche che li contengono.
EP0285008A3 (en) The use of buspirone for preparing a pharmaceutical composition for the treatment of alcohol abuse
DE68902531D1 (de) Dispergierbare zubereitung.
IL86423A0 (en) Pharmaceutical compositions for the treatment of alzheimer's disease
AU6667790A (en) Sustained release compositions for treating periodontal disease
HUT57204A (en) Process for producing 4-fluoro-2-///4-methoxy-2-pyridinyl/-methyl/-sulfinyl/-1h-benzimidazol with gastric acid secration-diminishing activity and pharmaceutical compositions containing them
HUT50334A (en) Process for producing arylpiperazinyl-alkilenephenyl-p-heterocycluc compounds, pharmaceutically acceptable acid addition salts thereof and pharmaceutical compositions comprising the compounds as active ingredient
CA2010022A1 (fr) Composes anesthesiques oraux
DE2967356D1 (en) Cephalosporin derivatives, process for their preparation and pharmaceutical compositions containing them
GR3004863T3 (fr)
IT8720438A0 (it) Esteri di 1,4:3,6-dianidrosorbitolo-2-mononitrato e 5-mononitrato, loro procedimento di preparazione e loro composizioni farmaceutiche.
EP0218953A3 (fr) Dérivés de l'acide 19,20-bis-nor-prostanoique à activité anti-ulcéreuse et anorétique, leur procédé de préparation et compositions pharmaceutiques
GR3006606T3 (fr)
DE3688787D1 (de) Herstellung eines arzneimittels gegen arthritis und rheumatismus.
EP0334281A3 (fr) Dérivés de céphalosporine et procédé de leur préparation
EP0373388A3 (fr) Dérivés de pénème et procédé de préparation
HUT53288A (en) Process for production of medical compositions for animals against endoparasite
HU895215D0 (en) Process for the preparation of pharmaceutical compositions against diseases caused by retrovirus
IT1222140B (it) Composti ad attivita' antivirale,procedimento per la loro preparazione e relative composizioni farmaceutiche
ITMI930273A0 (it) Composti terapeuticamente attivi, utili per il trattamento di malattie connesse con alterata funzionalita' del sistema immunitario procedimento per la loro preparazione e composizione farmaceutiche che li contengono
RU93047670A (ru) Соединения общей формулы, способы их получения, фармацевтическая композиция и пестициды на их основе
IT8922245A0 (it) Esteri dell'acido 6-d(-)-alfa-(4-etil-2,3-diosso-1- piperazinilcarbonilamino)-alfa-fenilacetamido penicillanico, procedimento per la loro preparazione e relative composizioni farmaceutiche
IT1152211B (it) Ammidi dell'acido teofillin-7-acetico, procedimenti per la loro preparazione e relative composizioni farmaceutiche

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed